New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 6, 2013
08:40 EDTROSGRosetta Genomics reports first payment from UK NHS for Cancer Origin Test
Rosetta Genomics announces that the National Health Service, or NHS, of the United Kingdom, has made its first payment to the company for use of the Rosetta Cancer Origin Test on a British citizen. The accurate identification of the primary tumor type in primary and metastatic cancer including cancer of unknown or uncertain primary is important in guiding clinician treatment decisions to maximize patient outcomes.
News For ROSG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 8, 2015
07:24 EDTROSGAegis to hold a conference
Subscribe for More Information
September 30, 2015
09:18 EDTROSGRosetta Genomics announces partnership with FNApath
Rosetta Genomics announces that the company has reached an agreement-in-principle with FNApath of Little Rock, Arkansas, under which Rosetta Genomics will provide endocrinologists initially testing their patients for thyroid cancer with the option of using a pathologist or laboratory of their own choosing, or FNApath, a centralized laboratory with an expertise in diagnosing thyroid cancer. In the event of an indeterminate result, the sample would then be tested with RosettaGx Thyroid Reveal, the company's thyroid neoplasia assay for the differential diagnosis of indeterminate fine needle aspirates, or FNAs.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use